|
[1]
|
Yue, M., Xiao, L., Yan, R., Li, X. and Yang, W. (2023) Pyroptosis in Neurodegenerative Diseases: What Lies Beneath the Tip of the Iceberg? International Reviews of Immunology, 42, 258-273. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Cova, I., Markova, A., Campini, I., Grande, G., Mariani, C. and Pomati, S. (2017) Worldwide Trends in the Prevalence of Dementia. Journal of the Neurological Sciences, 379, 259-260. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Jellinger, K.A. (2010) Basic Mechanisms of Neurodegeneration: A Critical Update. Journal of Cellular and Molecular Medicine, 14, 457-487. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Miao, Y., Quan, W., Dong, X., Gan, J., Ji, C., Wang, J., et al. (2023) A Bibliometric Analysis of Ferroptosis, Necroptosis, Pyroptosis, and Cuproptosis in Cancer from 2012 to 2022. Cell Death Discovery, 9, Article No. 129. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Reichert, C.O., de Freitas, F.A., Sampaio-Silva, J., Rokita-Rosa, L., Barros, P.d.L., Levy, D., et al. (2020) Ferroptosis Mechanisms Involved in Neurodegenerative Diseases. International Journal of Molecular Sciences, 21, Article 8765. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Diao, C., Chen, Z., Qiu, T., Liu, H., Yang, Y., Liu, X., et al. (2019) Inhibition of PRMT5 Attenuates Oxidative Stress-Induced Pyroptosis via Activation of the Nrf2/HO-1 Signal Pathway in a Mouse Model of Renal Ischemia-Reperfusion Injury. Oxidative Medicine and Cellular Longevity, 2019, Article ID: 2345658. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Dixon, S.J., Lemberg, K.M., Lamprecht, M.R., Skouta, R., Zaitsev, E.M., Gleason, C.E., et al. (2012) Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death. Cell, 149, 1060-1072. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Wei, Y., Lv, H., Shaikh, A.B., Han, W., Hou, H., Zhang, Z., et al. (2020) Directly Targeting Glutathione Peroxidase 4 May Be More Effective than Disrupting Glutathione on Ferroptosis-Based Cancer Therapy. Biochimica et Biophysica Acta (BBA)—General Subjects, 1864, Article ID: 129539. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Zhou, L., Zhang, R., Jia, C., Kang, L., Zhang, Z., Zhang, H., et al. (2022) Ferroptosis: A Potential Target for the Intervention of Intervertebral Disc Degeneration. Frontiers in Endocrinology, 13, Article 1042060. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Chu, J., Li, J., Sun, L. and Wei, J. (2023) The Role of Cellular Defense Systems of Ferroptosis in Parkinson’s Disease and Alzheimer’s Disease. International Journal of Molecular Sciences, 24, Article 14108. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Dixon, S.J. and Olzmann, J.A. (2024) The Cell Biology of Ferroptosis. Nature Reviews Molecular Cell Biology, 25, 424-442. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Rouault, T.A. (2012) Regulation of Iron Metabolism in Mammalian Cells. In: Anderson, G. and McLaren, G., Eds., Iron Physiology and Pathophysiology in Humans, Humana Press, 51-62. [Google Scholar] [CrossRef]
|
|
[13]
|
Bou-Abdallah, F. (2012) Transferrins: Molecular Mechanisms of Iron Transport and Disorders. Biochimica et Biophysica Acta (BBA)—General Subjects, 1820, 157-158. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Mason, A.B., Byrne, S.L., Everse, S.J., Roberts, S.E., Chasteen, N.D., Smith, V.C., et al. (2009) A Loop in the n‐Lobe of Human Serum Transferrin Is Critical for Binding to the Transferrin Receptor as Revealed by Mutagenesis, Isothermal Titration Calorimetry, and Epitope Mapping. Journal of Molecular Recognition, 22, 521-529. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Ohgami, R.S., Campagna, D.R., Greer, E.L., Antiochos, B., McDonald, A., Chen, J., et al. (2005) Identification of a Ferrireductase Required for Efficient Transferrin-Dependent Iron Uptake in Erythroid Cells. Nature Genetics, 37, 1264-1269. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Lawrence, C.M., Sendamarai, A.K., Ohgami, R.S. and Fleming, M.D. (2008) Structural Studies of Steap3, the Human Erythroid Ferric Reductase, Suggest a Gating Mechanism for Electron Transfer across the Endosomal Membrane. The FASEB Journal, 22, 813.16. [Google Scholar] [CrossRef]
|
|
[17]
|
Gao, G., Li, J., Zhang, Y. and Chang, Y. (2019) Cellular Iron Metabolism and Regulation. In: Chang, Y.Z., Ed., Brain Iron Metabolism and CNS Diseases, Springer, 21-32. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Zhou, J., Ye, S., Fujiwara, T., Manolagas, S.C. and Zhao, H. (2013) Steap4 Plays a Critical Role in Osteoclastogenesis in Vitro by Regulating Cellular Iron/Reactive Oxygen Species (ROS) Levels and Camp Response Element-Binding Protein (CREB) Activation. Journal of Biological Chemistry, 288, 30064-30074. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
He, Y., Liu, X., Xing, L., Wan, X., Chang, X. and Jiang, H. (2020) Fenton Reaction-Independent Ferroptosis Therapy via Glutathione and Iron Redox Couple Sequentially Triggered Lipid Peroxide Generator. Biomaterials, 241, Article ID: 119911. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Wang, S., Luo, J., Zhang, Z., et al. (2018) Iron and Magnetic: New Research Direction of the Ferroptosis-Based Cancer Therapy. American Journal of Cancer Research, 8, 1933-1946.
|
|
[21]
|
Kwun, M.S. and Lee, D.G. (2023) Ferroptosis-Like Death in Microorganisms: A Novel Programmed Cell Death Following Lipid Peroxidation. Journal of Microbiology and Biotechnology, 33, 992-997. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Zhang, B., Liu, H., Wang, Y. and Zhang, Y. (2024) Ros-Responsive and Self-Catalytic Nanocarriers for a Combination of Chemotherapy and Reinforced Ferroptosis against Breast Cancer. ACS Biomaterials Science & Engineering, 10, 6352-6362. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Liang, Y., Zhang, L., Peng, C., Zhang, S., Chen, S., Qian, X., et al. (2021) Tumor Microenvironments Self-Activated Nanoscale Metal-Organic Frameworks for Ferroptosis Based Cancer Chemodynamic/Photothermal/Chemo Therapy. Acta Pharmaceutica Sinica B, 11, 3231-3243. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Huang, L., Feng, J., Zhu, J., Yang, J., Xiong, W., Lu, X., et al. (2023) A Strategy of Fenton Reaction Cycloacceleration for High‐Performance Ferroptosis Therapy Initiated by Tumor Microenvironment Remodeling. Advanced Healthcare Materials, 12, e2203362. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Tan, W.B. and Chng, S. (2025) Primary Role of the Tol-Pal Complex in Bacterial Outer Membrane Lipid Homeostasis. Nature Communications, 16, Article No. 2293. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Anamourlis, C. (2020) The Cell Membrane. Southern African Journal of Anaesthesia and Analgesia, 26, a1314. [Google Scholar] [CrossRef]
|
|
[27]
|
Chen, J. and Chen, X. (2022) Editorial: Ferroptosis as New Therapeutic Targets in Cancer: From Molecular Mechanisms to Therapeutic Opportunities. Frontiers in Pharmacology, 13, Article 1019395. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Wiktorowska-Owczarek, A., Berezińska, M. and Nowak, J.Z. (2015) PUFAs: Structures, Metabolism and Functions. Advances in Clinical and Experimental Medicine, 24, 931-941. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Mortensen, M.S., Ruiz, J. and Watts, J.L. (2023) Polyunsaturated Fatty Acids Drive Lipid Peroxidation during Ferroptosis. Cells, 12, Article 804. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Liu, Y., Chen, J., He, Z., Luo, H., Liu, X., Sun, Y., et al. (2023) Ferrocene-Liposome-PEG: A Robust ˙OH/Lipid Peroxide Nano-Converter for Inducing Tumor Ferroptosis. Biomaterials Science, 11, 542-553. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Liang, D., Deng, L. and Jiang, X. (2020) A New Checkpoint against Ferroptosis. Cell Research, 30, 3-4. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Yang, W.S., SriRamaratnam, R., Welsch, M.E., Shimada, K., Skouta, R., Viswanathan, V.S., et al. (2014) Regulation of Ferroptotic Cancer Cell Death by GPX4. Cell, 156, 317-331. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Imai, H., Matsuoka, M., Kumagai, T., Sakamoto, T. and Koumura, T. (2017) Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis. In: Nagata, S. and Nakano, H., Eds., Apoptotic and Non-Apoptotic Cell Death, Springer, 143-170. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Li, F., Long, H., Zhou, Z., Luo, H., Xu, S. and Gao, L. (2022) System Xc−/GSH/GPX4 Axis: An Important Antioxidant System for the Ferroptosis in Drug-Resistant Solid Tumor Therapy. Frontiers in Pharmacology, 13, Article 910292. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Hu, C., Nydes, M., Shanley, K.L., Morales Pantoja, I.E., Howard, T.A. and Bizzozero, O.A. (2019) Reduced Expression of the Ferroptosis Inhibitor Glutathione Peroxidase‐4 in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. Journal of Neurochemistry, 148, 426-439. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Song, Y., Lei, H., Yu, D., Zhu, H., Hao, M., Cui, R., et al. (2024) Endogenous Chemicals Guard Health through Inhibiting Ferroptotic Cell Death. BioFactors, 50, 266-293. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Yuvaraj, S., Premkumar, V.G., Vijayasarathy, K., Gangadaran, S.G.D. and Sachdanandam, P. (2008) Augmented Antioxidant Status in Tamoxifen Treated Postmenopausal Women with Breast Cancer on Co-Administration with Coenzyme Q10, Niacin and Riboflavin. Cancer Chemotherapy and Pharmacology, 61, 933-941. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Galluzzi, L., Vitale, I., Aaronson, S.A., Abrams, J.M., Adam, D., Agostinis, P., et al. (2018) Molecular Mechanisms of Cell Death: Recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death & Differentiation, 25, 486-541. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., et al. (2015) Cleavage of GSDMD by Inflammatory Caspases Determines Pyroptotic Cell Death. Nature, 526, 660-665. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Ramos-Junior, E.S. and Morandini, A.C. (2017) Gasdermin: A New Player to the Inflammasome Game. Biomedical Journal, 40, 313-316. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Fang, Y., Tian, S., Pan, Y., Li, W., Wang, Q., Tang, Y., et al. (2020) Pyroptosis: A New Frontier in Cancer. Biomedicine & Pharmacotherapy, 121, Article ID: 109595. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Zhu, J., Ma, Y., Wang, J., Wang, Y., Ali, W., Zou, H., et al. (2023) The Mechanism of Osteoprotegerin-Induced Osteoclast Pyroptosis in Vitro. International Journal of Molecular Sciences, 24, 1518. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Friedmann Angeli, J.P., Schneider, M., Proneth, B., Tyurina, Y.Y., Tyurin, V.A., Hammond, V.J., et al. (2014) Inactivation of the Ferroptosis Regulator Gpx4 Triggers Acute Renal Failure in Mice. Nature Cell Biology, 16, 1180-1191. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Zheng, D., Liwinski, T. and Elinav, E. (2020) Inflammasome Activation and Regulation: Toward a Better Understanding of Complex Mechanisms. Cell Discovery, 6, Article No. 36. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Blevins, H.M., Xu, Y., Biby, S. and Zhang, S. (2022) The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases. Frontiers in Aging Neuroscience, 14, Article 879021. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Doyle, S., Ozaki, E. and Campbell, M. (2015) Targeting the NLRP3 Inflammasome in Chronic Inflammatory Diseases: Current Perspectives. Journal of Inflammation Research, 8, 15-27. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Li, S., Sun, Y., Song, M., Song, Y., Fang, Y., Zhang, Q., et al. (2021) NLRP3/Caspase-1/GSDMD-Mediated Pyroptosis Exerts a Crucial Role in Astrocyte Pathological Injury in Mouse Model of Depression. JCI Insight, 6, e146852. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Dai, Z., Liu, W., Chen, X., Wang, X., Li, J. and Zhang, X. (2023) Gasdermin D-Mediated Pyroptosis: Mechanisms, Diseases, and Inhibitors. Frontiers in Immunology, 14, Article 1178662. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Tsuchiya, K., Hosojima, S., Hara, H., Kushiyama, H., Mahib, M.R., Kinoshita, T., et al. (2021) Gasdermin D Mediates the Maturation and Release of IL-1α Downstream of Inflammasomes. Cell Reports, 34, Article ID: 108887. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
He, W., Wan, H., Hu, L., Chen, P., Wang, X., Huang, Z., et al. (2015) Gasdermin D Is an Executor of Pyroptosis and Required for Interleukin-1β Secretion. Cell Research, 25, 1285-1298. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Martinon, F., Burns, K. and Tschopp, J. (2002) The Inflammasome: A Molecular Platform Triggering Activation of Inflammatory Caspases and Processing of proIL-β. Molecular Cell, 10, 417-426. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Platnich, J.M. and Muruve, D.A. (2019) Nod-Like Receptors and Inflammasomes: A Review of Their Canonical and Non-Canonical Signaling Pathways. Archives of Biochemistry and Biophysics, 670, 4-14. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Xia, X., Wang, X., Cheng, Z., Qin, W., Lei, L., Jiang, J., et al. (2019) The Role of Pyroptosis in Cancer: Pro-Cancer or Pro-“Host”? Cell Death & Disease, 10, Article No. 650. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Dinarello, C.A. (2009) Immunological and Inflammatory Functions of the Interleukin-1 Family. Annual Review of Immunology, 27, 519-550. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Babcock, I.W., Sibley, L.A., Labuzan, S.A., Cowan, M.N., Sethi, I., Alemu, S., et al. (2024) Caspase-1 in Cx3cr1-Expressing Cells Drives an Il-18-Dependent T Cell Response That Promotes Parasite Control during Acute Toxoplasma gondii Infection. PLOS Pathogens, 20, e1012006. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Vecchié, A., Bonaventura, A., Toldo, S., Dagna, L., Dinarello, C.A. and Abbate, A. (2021) IL‐18 and Infections: Is There a Role for Targeted Therapies? Journal of Cellular Physiology, 236, 1638-1657. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Linder, A. and Hornung, V. (2020) Irgm2 and Gate‐16 Put a Break on Caspase‐11 Activation. EMBO reports, 21, article No. EMBR202051787. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Rathinam, V.A.K., Zhao, Y. and Shao, F. (2019) Innate Immunity to Intracellular LPS. Nature Immunology, 20, 527-533. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Ye, J., Zeng, B., Zhong, M., Li, H., Xu, L., Shu, J., et al. (2021) Scutellarin Inhibits Caspase-11 Activation and Pyroptosis in Macrophages via Regulating PKA Signaling. Acta Pharmaceutica Sinica B, 11, 112-126. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Wright, S.S., Vasudevan, S.O. and Rathinam, V.A. (2022) Mechanisms and Consequences of Noncanonical Inflammasome-Mediated Pyroptosis. Journal of Molecular Biology, 434, Article ID: 167245. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Rathinam, V.A.K., Vanaja, S.K., Waggoner, L., Sokolovska, A., Becker, C., Stuart, L.M., et al. (2012) TRIF Licenses Caspase-11-Dependent NLRP3 Inflammasome Activation by Gram-Negative Bacteria. Cell, 150, 606-619. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Binder, C.J., Papac-Milicevic, N. and Witztum, J.L. (2016) Innate Sensing of Oxidation-Specific Epitopes in Health and Disease. Nature Reviews Immunology, 16, 485-497. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Atalay Ekiner, S., Gęgotek, A. and Skrzydlewska, E. (2024) Inflammasome Activity Regulation by PUFA Metabolites. Frontiers in Immunology, 15, Article 1452749. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Ge, J., Li, X., Xia, Y., Chen, Z., Xie, C., Zhao, Y., et al. (2024) Recent Advances in NLRP3 Inflammasome in Corneal Diseases: Preclinical Insights and Therapeutic Implications. The Ocular Surface, 34, 392-405. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Xian, H., Watari, K., Sanchez-Lopez, E., Offenberger, J., Onyuru, J., Sampath, H., et al. (2022) Oxidized DNA Fragments Exit Mitochondria via mPTP-and VDAC-Dependent Channels to Activate NLRP3 Inflammasome and Interferon Signaling. Immunity, 55, 1370-1385.e8. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Wang, J., Song, N., Jiang, H., Wang, J. and Xie, J. (2013) Pro-Inflammatory Cytokines Modulate Iron Regulatory Protein 1 Expression and Iron Transportation through Reactive Oxygen/Nitrogen Species Production in Ventral Mesencephalic Neurons. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1832, 618-625. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Sendtner, N., Seitz, R., Brandl, N., Müller, M. and Gülow, K. (2025) Reactive Oxygen Species across Death Pathways: Gatekeepers of Apoptosis, Ferroptosis, Pyroptosis, Paraptosis, and Beyond. International Journal of Molecular Sciences, 26, Article 10240. [Google Scholar] [CrossRef]
|
|
[68]
|
Li, J., Jia, Y., Ding, Y., Bai, J., Cao, F. and Li, F. (2023) The Crosstalk between Ferroptosis and Mitochondrial Dynamic Regulatory Networks. International Journal of Biological Sciences, 19, 2756-2771. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Próchnicki, T., Vasconcelos, M.B., Robinson, K.S., Mangan, M.S.J., De Graaf, D., Shkarina, K., et al. (2023) Mitochondrial Damage Activates the NLRP10 Inflammasome. Nature Immunology, 24, 595-603. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Di Lorenzo, R., Marzetti, E., Coelho-Junior, H.J., Calvani, R., Pesce, V., Landi, F., et al. (2025) Iron Metabolism and Muscle Aging: Where Ferritinophagy Meets Mitochondrial Quality Control. Cells, 14, Article 672. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Khatun, J., Gelles, J.D. and Chipuk, J.E. (2024) Dynamic Death Decisions: How Mitochondrial Dynamics Shape Cellular Commitment to Apoptosis and Ferroptosis. Developmental Cell, 59, 2549-2565. [Google Scholar] [CrossRef] [PubMed]
|
|
[72]
|
(2023) 2023 Alzheimer’s Disease Facts and Figures. Alzheimer’s & Dementia, 19, 1598-1695.
|
|
[73]
|
Gallaway, P., Miyake, H., Buchowski, M., Shimada, M., Yoshitake, Y., Kim, A., et al. (2017) Physical Activity: A Viable Way to Reduce the Risks of Mild Cognitive Impairment, Alzheimer’s Disease, and Vascular Dementia in Older Adults. Brain Sciences, 7, Article 22. [Google Scholar] [CrossRef] [PubMed]
|
|
[74]
|
Everett, J., Brooks, J., Lermyte, F., O’Connor, P.B., Sadler, P.J., Dobson, J., et al. (2020) Iron Stored in Ferritin Is Chemically Reduced in the Presence of Aggregating Aβ(1-42). Scientific Reports, 10, Article No. 10332. [Google Scholar] [CrossRef] [PubMed]
|
|
[75]
|
Onukwufor, J.O., Dirksen, R.T. and Wojtovich, A.P. (2022) Iron Dysregulation in Mitochondrial Dysfunction and Alzheimer’s Disease. Antioxidants, 11, Article 692. [Google Scholar] [CrossRef] [PubMed]
|
|
[76]
|
Wang, L., Tang, Z., Li, B., Peng, Y., Yang, X., Xiao, Y., et al. (2024) Myricetin Ameliorates Cognitive Impairment in 3 × Tg Alzheimer’s Disease Mice by Regulating Oxidative Stress and Tau Hyperphosphorylation. Biomedicine & Pharmacotherapy, 177, Article ID: 116963. [Google Scholar] [CrossRef] [PubMed]
|
|
[77]
|
Khan, M.S., Hu, Q., Okeibunor, K., Ma, L. and Bopassa, J.C. (2025) Targeting Ferroptosis for Neuroprotection: Potential Therapeutic Avenues in Neurodegenerative and Neuropsychiatric Diseases. Frontiers in Physiology, 16, Article 1641323. [Google Scholar] [CrossRef]
|
|
[78]
|
Park, M.W., Cha, H.W., Kim, J., Kim, J.H., Yang, H., Yoon, S., et al. (2021) NOX4 Promotes Ferroptosis of Astrocytes by Oxidative Stress-Induced Lipid Peroxidation via the Impairment of Mitochondrial Metabolism in Alzheimer’s Diseases. Redox Biology, 41, Article ID: 101947. [Google Scholar] [CrossRef] [PubMed]
|
|
[79]
|
Telling, N.D., Everett, J., Collingwood, J.F., Dobson, J., van der Laan, G., Gallagher, J.J., et al. (2017) Iron Biochemistry Is Correlated with Amyloid Plaque Morphology in an Established Mouse Model of Alzheimer’s Disease. Cell Chemical Biology, 24, 1205-1215.e3. [Google Scholar] [CrossRef] [PubMed]
|
|
[80]
|
Rogers, J.T., Bush, A.I., Cho, H., Smith, D.H., Thomson, A.M., Friedlich, A.L., et al. (2008) Iron and the Translation of the Amyloid Precursor Protein (APP) and Ferritin mRNAs: Riboregulation against Neural Oxidative Damage in Alzheimer’s Disease. Biochemical Society Transactions, 36, 1282-1287. [Google Scholar] [CrossRef] [PubMed]
|
|
[81]
|
Chen, X. and Yan, S.D. (2006) Mitochondrial Aβ a Potential Cause of Metabolic Dysfunction in Alzheimer’s Disease. IUBMB Life, 58, 686-694. [Google Scholar] [CrossRef] [PubMed]
|
|
[82]
|
Peng, Y., Chang, X. and Lang, M. (2021) Iron Homeostasis Disorder and Alzheimer’s Disease. International Journal of Molecular Sciences, 22, Article 12442. [Google Scholar] [CrossRef] [PubMed]
|
|
[83]
|
Tomata, Y., Larsson, S.C. and Hägg, S. (2020) Polyunsaturated Fatty Acids and Risk of Alzheimer’s Disease: A Mendelian Randomization Study. European Journal of Nutrition, 59, 1763-1766. [Google Scholar] [CrossRef] [PubMed]
|
|
[84]
|
Mett, J. (2021) The Impact of Medium Chain and Polyunsaturated ω-3-Fatty Acids on Amyloid-β Deposition, Oxidative Stress and Metabolic Dysfunction Associated with Alzheimer’s Disease. Antioxidants, 10, Article 1991. [Google Scholar] [CrossRef] [PubMed]
|
|
[85]
|
Mandal, P.K., Saharan, S., Tripathi, M. and Murari, G. (2015) Brain Glutathione Levels—A Novel Biomarker for Mild Cognitive Impairment and Alzheimer’s Disease. Biological Psychiatry, 78, 702-710. [Google Scholar] [CrossRef] [PubMed]
|
|
[86]
|
Yong, Y., Yan, L., Wei, J., Feng, C., Yu, L., Wu, J., et al. (2024) A Novel Ferroptosis Inhibitor, Thonningianin A, Improves Alzheimer’s Disease by Activating GPX4. Theranostics, 14, 6161-6184. [Google Scholar] [CrossRef] [PubMed]
|
|
[87]
|
Duffy, S.L., Lagopoulos, J., Hickie, I.B., Diamond, K., Graeber, M.B., Lewis, S.J.G., et al. (2014) Glutathione Relates to Neuropsychological Functioning in Mild Cognitive Impairment. Alzheimer’s & Dementia, 10, 67-75. [Google Scholar] [CrossRef] [PubMed]
|
|
[88]
|
Benarroch, E. (2023) What Is the Role of Ferroptosis in Neurodegeneration? Neurology, 101, 312-319. [Google Scholar] [CrossRef] [PubMed]
|
|
[89]
|
Cao, Y., Xiao, W., Liu, S. and Zeng, Y. (2023) Ferroptosis: Underlying Mechanism and the Crosstalk with Other Modes of Neuronal Death after Intracerebral Hemorrhage. Frontiers in Cellular Neuroscience, 17, Article 1080344. [Google Scholar] [CrossRef] [PubMed]
|
|
[90]
|
Liu, Y., Zhao, D., Yang, F., Ye, C., Chen, Z., Chen, Y., et al. (2024) In Situ Self-Assembled Phytopolyphenol-Coordinated Intelligent Nanotherapeutics for Multipronged Management of Ferroptosis-Driven Alzheimer’s Disease. ACS Nano, 18, 7890-7906. [Google Scholar] [CrossRef] [PubMed]
|
|
[91]
|
Poewe, W., Seppi, K., Tanner, C.M., Halliday, G.M., Brundin, P., Volkmann, J., et al. (2017) Parkinson Disease. Nature Reviews Disease Primers, 3, Article No. 17013. [Google Scholar] [CrossRef] [PubMed]
|
|
[92]
|
Tanner, C.M. and Ostrem, J.L. (2024) Parkinson’s Disease. New England Journal of Medicine, 391, 442-452. [Google Scholar] [CrossRef] [PubMed]
|
|
[93]
|
Caminiti, S.P., Presotto, L., Baroncini, D., Garibotto, V., Moresco, R.M., Gianolli, L., et al. (2017) Axonal Damage and Loss of Connectivity in Nigrostriatal and Mesolimbic Dopamine Pathways in Early Parkinson’s Disease. NeuroImage: Clinical, 14, 734-740. [Google Scholar] [CrossRef] [PubMed]
|
|
[94]
|
Yang, L., Mao, K., Yu, H. and Chen, J. (2020) Neuroinflammatory Responses and Parkinson’ Disease: Pathogenic Mechanisms and Therapeutic Targets. Journal of Neuroimmune Pharmacology, 15, 830-837. [Google Scholar] [CrossRef] [PubMed]
|
|
[95]
|
Lee, Y., Lee, S., Chang, S. and Lee, J. (2019) Significant Roles of Neuroinflammation in Parkinson’s Disease: Therapeutic Targets for PD Prevention. Archives of Pharmacal Research, 42, 416-425. [Google Scholar] [CrossRef] [PubMed]
|
|
[96]
|
Subramaniam, S.R. and Chesselet, M. (2013) Mitochondrial Dysfunction and Oxidative Stress in Parkinson’s Disease. Progress in Neurobiology, 106, 17-32. [Google Scholar] [CrossRef] [PubMed]
|
|
[97]
|
Wong, Y.C. and Krainc, D. (2017) α-Synuclein Toxicity in Neurodegeneration: Mechanism and Therapeutic Strategies. Nature Medicine, 23, 1-13. [Google Scholar] [CrossRef] [PubMed]
|
|
[98]
|
Alushaj, E., Handfield-Jones, N., Kuurstra, A., Morava, A., Menon, R.S., Owen, A.M., et al. (2024) Increased Iron in the Substantia Nigra Pars Compacta Identifies Patients with Early Parkinson’s Disease: A 3T and 7T MRI Study. NeuroImage: Clinical, 41, Article ID: 103577. [Google Scholar] [CrossRef] [PubMed]
|
|
[99]
|
Bisaglia, M., Soriano, M.E., Arduini, I., Mammi, S. and Bubacco, L. (2010) Molecular Characterization of Dopamine-Derived Quinones Reactivity toward NADH and Glutathione: Implications for Mitochondrial Dysfunction in Parkinson Disease. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1802, 699-706. [Google Scholar] [CrossRef] [PubMed]
|
|
[100]
|
Epifane-de-Assunção, M.C., Bispo, A.G., Ribeiro-dos-Santos, Â. and Cavalcante, G.C. (2025) Molecular Alterations in Core Subunits of Mitochondrial Complex I and Their Relation to Parkinson’s Disease. Molecular Neurobiology, 62, 6968-6982. [Google Scholar] [CrossRef] [PubMed]
|
|
[101]
|
Chen, Z., Pan, C., Ruan, X., Lei, L., Lin, S., Wang, Y., et al. (2023) Evaluation of Ferritin and TfR Level in Plasma Neural-Derived Exosomes as Potential Markers of Parkinson’s Disease. Frontiers in Aging Neuroscience, 15, Article 1216905. [Google Scholar] [CrossRef] [PubMed]
|
|
[102]
|
Bai, L., Yan, F., Deng, R., Gu, R., Zhang, X. and Bai, J. (2021) Thioredoxin-1 Rescues MPP+/MPTP-Induced Ferroptosis by Increasing Glutathione Peroxidase 4. Molecular Neurobiology, 58, 3187-3197. [Google Scholar] [CrossRef] [PubMed]
|
|
[103]
|
Liu, T., Wang, P., Yin, H., Wang, X., Lv, J., Yuan, J., et al. (2023) Rapamycin Reverses Ferroptosis by Increasing Autophagy in MPTP/MPP+-Induced Models of Parkinson’s Disease. Neural Regeneration Research, 18, 2514-2519. [Google Scholar] [CrossRef] [PubMed]
|
|
[104]
|
Caron, N.S., Dorsey, E.R. and Hayden, M.R. (2018) Therapeutic Approaches to Huntington Disease: From the Bench to the Clinic. Nature Reviews Drug Discovery, 17, 729-750. [Google Scholar] [CrossRef] [PubMed]
|
|
[105]
|
Furlong, L.S., Jakabek, D., Power, B.D., Owens-Walton, C., Wilkes, F.A., Walterfang, M., et al. (2020) Morphometric in Vivo Evidence of Thalamic Atrophy Correlated with Cognitive and Motor Dysfunction in Huntington’s Disease: The IMAGE-HD Study. Psychiatry Research: Neuroimaging, 298, Article ID: 111048. [Google Scholar] [CrossRef] [PubMed]
|
|
[106]
|
Ma, J., Liu, J., Chen, S., Zhang, W., Wang, T., Cao, M., et al. (2024) Understanding the Mechanism of Ferroptosis in Neurodegenerative Diseases. Frontiers in Bioscience-Landmark, 29, Article 291. [Google Scholar] [CrossRef] [PubMed]
|
|
[107]
|
Chen, J., Marks, E., Lai, B., Zhang, Z., Duce, J.A., Lam, L.Q., et al. (2013) Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine. PLOS ONE, 8, e77023. [Google Scholar] [CrossRef] [PubMed]
|
|
[108]
|
Okada, N., Nakamura, S. and Shimazawa, M. (2023) 3-Nitropropionic Acid Enhances Ferroptotic Cell Death via Nox2-Mediated ROS Generation in STHdhQ111 Striatal Cells Carrying Mutant Huntingtin. Biological and Pharmaceutical Bulletin, 46, 177-186. [Google Scholar] [CrossRef] [PubMed]
|
|
[109]
|
Sharma, V., Verma, R., Sharma, P. and Singh, T.G. (2026) Programmed Cell Death Pathways in Huntington’s Disease: Spotlight on Ferroptosis and Pyroptosis. Neurological Sciences, 47, Article No. 83. [Google Scholar] [CrossRef]
|
|
[110]
|
Ji, Y., Zheng, K., Li, S., Ren, C., Shen, Y., Tian, L., et al. (2022) Insight into the Potential Role of Ferroptosis in Neurodegenerative Diseases. Frontiers in Cellular Neuroscience, 16, Article 1005182. [Google Scholar] [CrossRef] [PubMed]
|
|
[111]
|
Barrington, J., Lemarchand, E. and Allan, S.M. (2017) A Brain in Flame; Do Inflammasomes and Pyroptosis Influence Stroke Pathology? Brain Pathology, 27, 205-212. [Google Scholar] [CrossRef] [PubMed]
|
|
[112]
|
Shen, H., Han, C., Yang, Y., Guo, L., Sheng, Y., Wang, J., et al. (2021) Pyroptosis Executive Protein GSDMD as a Biomarker for Diagnosis and Identification of Alzheimer’s Disease. Brain and Behavior, 11, e02063. [Google Scholar] [CrossRef] [PubMed]
|
|
[113]
|
Olsen, I. and Singhrao, S.K. (2016) Inflammasome Involvement in Alzheimer’s Disease. Journal of Alzheimer’s Disease, 54, 45-53. [Google Scholar] [CrossRef] [PubMed]
|
|
[114]
|
Seol, Y., Ki, S., Ryu, H.L., Chung, S., Lee, J. and Ryu, H. (2020) How Microglia Manages Non-Cell Autonomous Vicious Cycling of Aβ Toxicity in the Pathogenesis of Ad. Frontiers in Molecular Neuroscience, 13, Article 593724. [Google Scholar] [CrossRef] [PubMed]
|
|
[115]
|
Flores, J., Noël, A., Foveau, B., Lynham, J., Lecrux, C. and LeBlanc, A.C. (2018) Caspase-1 Inhibition Alleviates Cognitive Impairment and Neuropathology in an Alzheimer’s Disease Mouse Model. Nature Communications, 9, Article No. 3916. [Google Scholar] [CrossRef] [PubMed]
|
|
[116]
|
Gibbons, G.S., Kim, S., Robinson, J.L., Changolkar, L., Irwin, D.J., Shaw, L.M., et al. (2019) Detection of Alzheimer’s Disease (AD) Specific Tau Pathology with Conformation-Selective Anti-Tau Monoclonal Antibody in Co-Morbid Frontotemporal Lobar Degeneration-Tau (FTLD-Tau). Acta Neuropathologica Communications, 7, Article No. 34. [Google Scholar] [CrossRef] [PubMed]
|
|
[117]
|
Li, Y., Xu, P., Shan, J., Sun, W., Ji, X., Chi, T., et al. (2020) Interaction between Hyperphosphorylated Tau and Pyroptosis in Forskolin and Streptozotocin Induced AD Models. Biomedicine & Pharmacotherapy, 121, Article ID: 109618. [Google Scholar] [CrossRef] [PubMed]
|
|
[118]
|
Liang, T., Zhang, Y., Wu, S., Chen, Q. and Wang, L. (2022) The Role of NLRP3 Inflammasome in Alzheimer’s Disease and Potential Therapeutic Targets. Frontiers in Pharmacology, 13, Article 845185. [Google Scholar] [CrossRef] [PubMed]
|
|
[119]
|
Han, C., Yang, Y., Guan, Q., Zhang, X., Shen, H., Sheng, Y., et al. (2020) New Mechanism of Nerve Injury in Alzheimer’s Disease: β‐Amyloid‐Induced Neuronal Pyroptosis. Journal of Cellular and Molecular Medicine, 24, 8078-8090. [Google Scholar] [CrossRef] [PubMed]
|
|
[120]
|
Cai, Y., Chai, Y., Fu, Y., Wang, Y., Zhang, Y., Zhang, X., et al. (2022) Salidroside Ameliorates Alzheimer’s Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis. Frontiers in Aging Neuroscience, 13, Article 809433. [Google Scholar] [CrossRef] [PubMed]
|
|
[121]
|
Lin, M.T. and Beal, M.F. (2006) Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases. Nature, 443, 787-795. [Google Scholar] [CrossRef] [PubMed]
|
|
[122]
|
Wang, S., Yuan, Y., Chen, N. and Wang, H. (2019) The Mechanisms of NLRP3 Inflammasome/Pyroptosis Activation and Their Role in Parkinson’s Disease. International Immunopharmacology, 67, 458-464. [Google Scholar] [CrossRef] [PubMed]
|
|
[123]
|
Zhou, Y., Lu, M., Du, R., Qiao, C., Jiang, C., Zhang, K., et al. (2016) Microrna-7 Targets Nod-Like Receptor Protein 3 Inflammasome to Modulate Neuroinflammation in the Pathogenesis of Parkinson’s Disease. Molecular Neurodegeneration, 11, Article No. 28. [Google Scholar] [CrossRef] [PubMed]
|
|
[124]
|
Albornoz, E.A., Woodruff, T.M. and Gordon, R. (2018) Inflammasomes in CNS Diseases. In: Cordero, M. and Alcocer-Gómez, E., Eds., Inflammasomes: Clinical and Therapeutic Implications, Springer, 41-60. [Google Scholar] [CrossRef] [PubMed]
|
|
[125]
|
Saewanee, N., Praputpittaya, T., Malaiwong, N., Chalorak, P. and Meemon, K. (2021) Neuroprotective Effect of Metformin on Dopaminergic Neurodegeneration and Α-Synuclein Aggregation in C. Elegans Model of Parkinson’s Disease. Neuroscience Research, 162, 13-21. [Google Scholar] [CrossRef] [PubMed]
|
|
[126]
|
Lázaro, D.F., Bellucci, A., Brundin, P. and Outeiro, T.F. (2020) Editorial: Protein Misfolding and Spreading Pathology in Neurodegenerative Diseases. Frontiers in Molecular Neuroscience, 12, Article 312. [Google Scholar] [CrossRef] [PubMed]
|
|
[127]
|
Cai, M., Zhuang, W., Lv, E., Liu, Z., Wang, Y., Zhang, W., et al. (2022) Kaemperfol Alleviates Pyroptosis and Microglia-Mediated Neuroinflammation in Parkinson’s Disease via Inhibiting p38MAPK/NF-κB Signaling Pathway. Neurochemistry International, 152, Article ID: 105221. [Google Scholar] [CrossRef] [PubMed]
|
|
[128]
|
Massaquoi, M.S., Liguore, W.A., Churchill, M.J., Moore, C., Melrose, H.L. and Meshul, C.K. (2020) Gait Deficits and Loss of Striatal Tyrosine Hydroxlase/Trk-B Are Restored Following 7,8-Dihydroxyflavone Treatment in a Progressive MPTP Mouse Model of Parkinson’s Disease. Neuroscience, 433, 53-71. [Google Scholar] [CrossRef] [PubMed]
|
|
[129]
|
Gordon, R., Albornoz, E.A., Christie, D.C., Langley, M.R., Kumar, V., Mantovani, S., et al. (2018) Inflammasome Inhibition Prevents α-Synuclein Pathology and Dopaminergic Neurodegeneration in Mice. Science Translational Medicine, 10, eaah4066. [Google Scholar] [CrossRef] [PubMed]
|
|
[130]
|
Bauernfeind, F., Bartok, E., Rieger, A., Franchi, L., Núñez, G. and Hornung, V. (2011) Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome. The Journal of Immunology, 187, 613-617. [Google Scholar] [CrossRef] [PubMed]
|
|
[131]
|
Chai, X., An, S., Zhang, Z., Zhou, Y., Gu, P., Zhao, W., et al. (2023) Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Parkinson’s Disease and Neuronal Damage through Inhibition of Microglia. Neural Regeneration Research, 18, 2291-2300. [Google Scholar] [CrossRef] [PubMed]
|
|
[132]
|
Kaplan, A. and Stockwell, B.R. (2012) Therapeutic Approaches to Preventing Cell Death in Huntington Disease. Progress in Neurobiology, 99, 262-280. [Google Scholar] [CrossRef] [PubMed]
|
|
[133]
|
Siew, J.J., Chen, H.M., et al. (2019) Galectin-3 Is Required for the Microglia-Mediated Brain Inflammation in a Model of Huntington’s Disease. Nature Communications, 10, Article No. 3473.
|
|
[134]
|
Paldino, E., D’Angelo, V., Sancesario, G. and Fusco, F.R. (2020) Pyroptotic Cell Death in the R6/2 Mouse Model of Huntington’s Disease: New Insight on the Inflammasome. Cell Death Discovery, 6, Article No. 69. [Google Scholar] [CrossRef] [PubMed]
|
|
[135]
|
Paldino, E., D’Angelo, V., Laurenti, D., Angeloni, C., Sancesario, G. and Fusco, F.R. (2020) Modulation of Inflammasome and Pyroptosis by Olaparib, a PARP-1 Inhibitor, in the R6/2 Mouse Model of Huntington’s Disease. Cells, 9, Article 2286. [Google Scholar] [CrossRef] [PubMed]
|
|
[136]
|
Chen, M., Ona, V.O., Li, M., Ferrante, R.J., Fink, K.B., Zhu, S., et al. (2000) Minocycline Inhibits Caspase-1 and Caspase-3 Expression and Delays Mortality in a Transgenic Mouse Model of Huntington Disease. Nature Medicine, 6, 797-801. [Google Scholar] [CrossRef] [PubMed]
|
|
[137]
|
Langley, M.R., Rangaraju, S., Dey, A. and Sarkar, S. (2022) Editorial: Environmental Effect on Neuroinflammation and Neurodegeneration. Frontiers in Cellular Neuroscience, 16, Article 935190. [Google Scholar] [CrossRef] [PubMed]
|